KSKatherine A. Su

Katherine A. Su

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katherine A. Su has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex-based differences in the anatomic distribution of cutaneous squamous cell carcinoma

    by Yuhree Kim, Jessica Feng, Katherine A. Su, Maryam M. Asgari

    Cutaneous squamous cell carcinoma (cSCC) is the second most common malignancy in the United States, and its incidence is increasing. Ultraviolet radiation is the main environmental risk factor for cSCCs; thus, they tend to arise on sun-exposed skin. Most publications cite the head and neck as the predominant location for cSCCs, but these papers do not account for the differential anatomic predication of cSCCs by sex. No prior studies have examined the differential distribution of cSCCs by sex, particularly invasive cSCCs that have the potential for recurrence and metastasis. We examined the association between cSCC tumor features, including anatomic site and invasiveness, by key patient features, including age and sex. Using an institutional cSCC registry, we identified 618 non-Hispanic white patients diagnosed with 2,111 histologically-confirmed cSCCs between 2000–2016. We found differential anatomic distributions of cSCC by patient sex. Men were more likely to have cSCCs arise on the head and neck (51.7%), whereas women were more likely to have cSCCs develop on the lower extremity (41.2%). Stratification by dichotomized age (younger [<65 years] vs. older [≥65 years]) revealed that nearly half of invasive cSCCs (47.7%) among older women arose on the lower extremities, whereas approximately half of the invasive cSCCs (52.4%) arose on the head and neck among older men. Lower extremities can be easily overlooked, particularly when practitioners perform waist-up-only skin examinations in time-limited settings. Understanding the anatomic predilection for invasive cSCCs by patient characteristics, including our findings, which suggest that the lower extremities are an important anatomic site for invasive cSCCs among women, can help further inform skin cancer screening and prevention efforts.


  • Open Access

    Enhancing the process for care delivery in a dermatology specialty clinic

    by Gil S. Weintraub, Katherine A. Su, Shadmehr Demehri, Maryam M. Asgari


  • Antihypertensive drug use and cSCC risk

    by K.A. Su, L.A. Habel, N.S. Achacoso, G.D. Friedman, M.M. Asgari


  • 降压药物使用和 cSCC 的风险

    by K.A. Su, L.A. Habel, N.S. Achacoso, G.D. Friedman, M.M. Asgari

  • Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma

    by K.A. Su, L.A. Habel, N.S. Achacoso, G.D. Friedman, M.M. Asgari

    Background Many antihypertensive drugs (ADs) are photosensitizing, heightening reactivity of the skin to sunlight. Photosensitizing ADs have been associated with lip cancer, but whether they impact the risk of cutaneous squamous cell carcinoma (cSCC) is unknown. Objectives To examine the association between AD use and cSCC risk among a cohort of non‐Hispanic white individuals with hypertension enrolled in a comprehensive integrated healthcare delivery system in northern California (n = 28 357). Methods Electronic pharmacy data were used to determine exposure to ADs, which were classified as photosensitizing, nonphotosensitizing or unknown, based on published literature. We identified patients who developed a cSCC during follow‐up (n = 3010). We used Cox modelling to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs). Covariates included age, sex, smoking, comorbidities, history of cSCC and actinic keratosis, survey year, healthcare utilization, length of health plan membership and history of photosensitizing AD use. Results Compared with nonuse of ADs, risk of cSCC was increased with ever having used photosensitizing ADs (aHR = 1·17, 95% CI 1·07–1·28) and ever having used ADs of unknown photosensitizing potential (aHR = 1·11, 95% CI 1·02–1·20), whereas no association was seen with ever having used nonphotosensitizing ADs (aHR = 0·99; 95% CI 0·91–1·07). Additionally, there was a modest increased risk with an increased number of prescriptions for photosensitizing ADs (aHR = 1·12, 95% CI 1·02–1·24; aHR = 1·19, 95% CI 1·06–1·34; aHR = 1·41, 95% CI 1·20–1·67 for one to seven, eight to 15 and ≥ 16 fills, respectively). Conclusions These findings provide moderate support for an increased cSCC risk among individuals treated with photosensitizing ADs.